Unity's AI ad platform Vector boosts ad network revenue 15% sequentially, with guidance for continued double-digit growth in Q3.

High dose and low dose TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in the 12 patients treated in Part A of REVEAL Phase 1/2 trials as of August 2025 data ...

AQUARIUS, the second Phase 3 study, is anticipated to initiate in the fourth quarter of 2025, pending funding availability. Long-term follow-up from the LUNA Phase 2 study continues, with two-year ...

PHILADELPHIA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, ...

Stay up to date with breaking developments in politics, energy, diplomacy, security and social movements across the region, ...

Learn how to build a scalable SaaS app without coding or a team. This step-by-step guide shows you how to leverage AI tools ...

In a striking and unprecedented move, the Trump administration has imposed a cumulative 50% tariff on Indian goods, ...

Revenue (GAAP) was $15.0 million in Q2 2025, outpacing analyst estimates by a wide margin and Revenue for the period surged to $15.0 million, tripling from Q2 2024. Research and development expenses ...

Straiker secures the future of AI by protecting agentic systems that reason, act, and adapt. With real-time, AI-native ...

The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping ...

Detailed price information for Rocket Pharmaceuticals Inc (RCKT-Q) from The Globe and Mail including charting and trades.

Kenya has officially eliminated Human African Trypanosomiasis (HAT), also known as sleeping sickness, as a public health problem, a milestone that signals the disease is no longer a major threat to ...